NEW YORK (GenomeWeb) – KromaTid today announced a Japanese distribution agreement with Tokyo Future Style for its directional Genomic Hybridization (dGH) and Pinpoint FISH products and services.

"Tokyo Future Style has a very focused approach to the Japanese market that we feel makes them a great fit for selling our products and services," KromaTid CEO Alex Vodenlich said in a statement.

The firm's dGH genomic imaging assay is able to determine DNA sequence, location, and orientation data in a single test, the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.